ENGINEERINGNET.EU -- The investment in Delft concerns a new laboratory for biotechnological research as well as a DSM contribution to the recently formed consortium for the Bioprocess Pilot Facility (BPF) for bio-research.
In Sittard-Geleen a new materials sciences research building will be realized on the Chemelot Campus.
Maxime Verhagen, the Dutch Minister of Economic Affairs, Agriculture and Innovation, is excited about DSM investment’s: "This will strengthen the position of the Dutch knowledge-based economy and secure our position among the world leaders in sectors such as agro/food, chemicals and energy. Moreover, the investment will generate jobs and revenues in economically difficult times."
BACKGROUND
Royal DSM is a global science-based company active in health, nutrition and materials. DSM’s 22,000 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext.
